DarioHealth Corp. (NASDAQ: DRIO) Obtains Significant Capital Infusion with $28.6 Million Investment Round

Aug 5, 2020

  • DarioHealth Corp. is an digital therapeutics (“DTx”) pioneer supplying remote health condition monitoring technology to caregivers and their patients
  • The company recently reported a successful private placement funding transaction that provides Dario with $28.6 million in aggregate gross proceeds to build Dario’s operational strategy
  • Dario’s technology allows clinical care providers to remotely observe data related to patients’ chronic conditions and also may “nudge” patients to sustain their own care
  • The novel coronavirus pandemic has increased the popularity of remote patient monitoring (“RPM”) services as a means of avoiding infection risks in public healthcare settings, and legislative changes have made it easier to receive insurance reimbursement for those services

Modern technology has opened the door for a revolution in healthcare services, allowing many patients with chronic diseases to lead full and active lifestyles that may take them far from their medical providers without significant fear of repercussions thanks to communication media that support expansive health networks and, of late, telehealth and remote patient monitoring measures.

DarioHealth (NASDAQ: DRIO), a digital therapeutics innovator dedicated to providing such technology to hospitals and other medical facilities to help ensure patients receive a proper standard of care even if they are not in-clinic, recently announced a round of successful fund-raising that will help the…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.